Company: VERA
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001140361-25-012034
Chunk: 40

Company: Vera Therapeutics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 40
---
 26

TABLE OF CONTENTS

EXECUTIVE COMPENSATION Our named executive officers for the year ended December 31, 2024, consisting of our principal executive officer and the next two most highly compensated executive officers, were:

| • | Marshall Fordyce, M.D., our President and Chief Executive Officer; |

| • | Jason Carter, our Chief Legal Officer, who joined us in November 2024; and |

| • | Robert Brenner, M.D., our Chief Medical Officer, who joined us in January 2024. |

As a result of being a smaller reporting company during the fiscal year ended December 31, 2024 under applicable SEC rules and regulations, we are permitted to include less detailed executive compensation disclosure in this proxy statement. However, our Compensation Committee is committed to providing the information necessary to help stockholders understand our executive compensation-related decisions. Accordingly, this section includes supplemental information regarding the 2024 executive compensation program for our named executive officers. Executive Compensation Practices The following table summarizes our executive compensation practices to highlight both the responsible practices we have implemented and the practices we have avoided to best serve our stockholders’ long-term interests.

| What We Do: 
 ✔           
 ✔           |     | Performance metrics tied to company performance. The performance metrics for our annual executive bonus plan are tied to company performance, aligning the interests of our executives with those of our stockholders.          
 Multi-year vesting requirements. The equity awards we grant to our executive officers generally vest over multi-year periods, consistent with current market practice and our retention objectives.                             |     | What We Do Not Do: 
 ✘                  
 ✘                  |     | No tax gross-ups.None of our compensation agreements and arrangements provides for tax “gross-ups.”                                                                                                                                                                                                          
 No special perquisites.We generally do not provide our executives with perquisites or other personal benefits that differ materially from those available to employees generally.                                                                                                                            |
|:------------|:----|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:-------------------|:----|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ✔           |     | Double-trigger termination rights. Our agreements with our executive officers require both a change-in-control and a termination of employment for full severance benefits, including any equity acceleration, to be triggered. |     | ✘                  |     | No retirement plans other than 401(k).We do not provide any pension or other retirement benefits to our executive officers, except that we offer all employees the right to participate in a company-sponsored